NCT06301477View on ClinicalTrials.gov

PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions
Inflammatory Bowel DiseasesCrohn Disease
Interventions
OTHER

Resistant Starch

7.5g/m2 or 5.0g/m2 (body surface area) resistant starch oral consumption

OTHER

Placebo

Placebo oral consumption of food-grade cornstarch

Trial Locations (1)

K1H 8L1

Children's Hospital of Eastern Ontario, Ottawa

All Listed Sponsors
lead

Children's Hospital of Eastern Ontario

OTHER

NCT06301477 - PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial | Biotech Hunter | Biotech Hunter